These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 26645497)

  • 1. From concept to clinic: Mathematically informed immunotherapy.
    Walker R; Enderling H
    Curr Probl Cancer; 2016; 40(1):68-83. PubMed ID: 26645497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adoptive T cell therapy for cancer in the clinic.
    June CH
    J Clin Invest; 2007 Jun; 117(6):1466-76. PubMed ID: 17549249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. On immunotherapies and cancer vaccination protocols: a mathematical modelling approach.
    Joshi B; Wang X; Banerjee S; Tian H; Matzavinos A; Chaplain MA
    J Theor Biol; 2009 Aug; 259(4):820-7. PubMed ID: 19446568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How much help does a vaccine-induced T-cell response need?
    Weber JS; Mulé JJ
    J Clin Invest; 2001 Mar; 107(5):553-4. PubMed ID: 11238555
    [No Abstract]   [Full Text] [Related]  

  • 5. Dendritic cells: a journey from laboratory to clinic.
    Cerundolo V; Hermans IF; Salio M
    Nat Immunol; 2004 Jan; 5(1):7-10. PubMed ID: 14699398
    [No Abstract]   [Full Text] [Related]  

  • 6. Synthetic immune niches for cancer immunotherapy.
    Weiden J; Tel J; Figdor CG
    Nat Rev Immunol; 2018 Mar; 18(3):212-219. PubMed ID: 28853444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunotherapy of surgical malignancies.
    Morse MA; Lyerly HK; Clay TM; Abdel-Wahab O; Chui SY; Garst J; Gollob J; Grossi PM; Kalady M; Mosca PJ; Onaitis M; Sampson JH; Seigler HF; Toloza EM; Tyler D; Vieweg J; Yang Y
    Curr Probl Surg; 2004 Jan; 41(1):15-132. PubMed ID: 14749625
    [No Abstract]   [Full Text] [Related]  

  • 8. Cancer immunotherapy: will expanding knowledge lead to success in pediatric oncology?
    Fry TJ; Lankester AC
    Hematol Oncol Clin North Am; 2010 Feb; 24(1):109-27. PubMed ID: 20113898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The molecular basis of cancer immunotherapy by cytotoxic T lymphocytes.
    Lindauer M; Stanislawski T; Häussler A; Antunes E; Cellary A; Huber C; Theobald M
    J Mol Med (Berl); 1998 Jan; 76(1):32-47. PubMed ID: 9462866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A review of dendritic cell therapy for cancer: progress and challenges.
    Mantia-Smaldone GM; Chu CS
    BioDrugs; 2013 Oct; 27(5):453-68. PubMed ID: 23592406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Tumor antigen-specific cytotoxic T lymphocytes and cancer immunotherapy - review].
    Liu Y
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2004 Apr; 12(2):244-8. PubMed ID: 15157343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current status and future applications of cellular therapies for cancer.
    Copier J; Bodman-Smith M; Dalgleish A
    Immunotherapy; 2011 Apr; 3(4):507-16. PubMed ID: 21463192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenovirus as vehicle for anticancer genetic immunotherapy.
    Gallo P; Dharmapuri S; Cipriani B; Monaci P
    Gene Ther; 2005 Oct; 12 Suppl 1():S84-91. PubMed ID: 16231059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Molecular targets for development of cancer immunotherapy].
    Kawakami Y
    Nihon Rinsho; 2012 Nov; 70 Suppl 8():144-8. PubMed ID: 23513828
    [No Abstract]   [Full Text] [Related]  

  • 15. [Antitumor immunity and cellular cancer therapies].
    Catros-Quemener V; Bouet F; Genetet N
    Med Sci (Paris); 2003 Jan; 19(1):43-53. PubMed ID: 12836191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [New directions in immunotherapy for malignant solid tumors].
    Okuno K; Sugiura F; Sukegawa Y; Inoue K
    Nihon Rinsho; 2012 Dec; 70(12):2075-86. PubMed ID: 23259377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimal control in a model of dendritic cell transfection cancer immunotherapy.
    Castiglione F; Piccoli B
    Bull Math Biol; 2006 Feb; 68(2):255-74. PubMed ID: 16794930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LiveCount Assay: concomitant measurement of cytolytic activity and phenotypic characterisation of CD8(+) T-cells by flow cytometry.
    Devêvre E; Romero P; Mahnke YD
    J Immunol Methods; 2006 Apr; 311(1-2):31-46. PubMed ID: 16527300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combinatorial cancer immunotherapy.
    Hodi FS; Dranoff G
    Adv Immunol; 2006; 90():341-68. PubMed ID: 16730268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antigen presentation by dendritic cells and their significance in antineoplastic immunotherapy.
    Bodey B; Siegel SE; Kaiser HE
    In Vivo; 2004; 18(1):81-100. PubMed ID: 15011756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.